Jacquot J - Search Results

1

Bone disease in cystic fibrosis: what's new?

Javier RM, Jacquot J. Javier RM, et al. Among authors: jacquot j. Joint Bone Spine. 2011 Oct;78(5):445-50. doi: 10.1016/j.jbspin.2010.11.015. Epub 2011 Jan 12. Joint Bone Spine. 2011. PMID: 21233000 Review.

2

Bone disease in cystic fibrosis: new pathogenic insights opening novel therapies.

Jacquot J, Delion M, Gangloff S, Braux J, Velard F. Jacquot J, et al. Osteoporos Int. 2016 Apr;27(4):1401-1412. doi: 10.1007/s00198-015-3343-3. Epub 2015 Oct 2. Osteoporos Int. 2016. PMID: 26431978 Review.

3

Bone demineralization is improved by ivacaftor in patients with cystic fibrosis carrying the p.Gly551Asp mutation.

Sermet-Gaudelus I, Delion M, Durieu I, Jacquot J, Hubert D. Sermet-Gaudelus I, et al. Among authors: jacquot j. J Cyst Fibros. 2016 Nov;15(6):e67-e69. doi: 10.1016/j.jcf.2016.09.003. Epub 2016 Oct 10. J Cyst Fibros. 2016. PMID: 27745802 Free article.

4

Enhanced F508del-CFTR channel activity ameliorates bone pathology in murine cystic fibrosis.

Le Henaff C, Haÿ E, Velard F, Marty C, Tabary O, Marie PJ, Jacquot JP. Le Henaff C, et al. Among authors: jacquot jp. Am J Pathol. 2014 Apr;184(4):1132-1141. doi: 10.1016/j.ajpath.2013.12.027. Epub 2014 Feb 11. Am J Pathol. 2014. PMID: 24529904

5

Cystic fibrosis transmembrane conductance regulator (CFTR) regulates the production of osteoprotegerin (OPG) and prostaglandin (PG) E2 in human bone.

Le Heron L, Guillaume C, Velard F, Braux J, Touqui L, Moriceau S, Sermet-Gaudelus I, Laurent-Maquin D, Jacquot J. Le Heron L, et al. Among authors: jacquot j. J Cyst Fibros. 2010 Jan;9(1):69-72. doi: 10.1016/j.jcf.2009.11.005. Epub 2009 Dec 14. J Cyst Fibros. 2010. PMID: 20005786 Free article.

6

The F508del mutation in cystic fibrosis transmembrane conductance regulator gene impacts bone formation.

Le Henaff C, Gimenez A, Haÿ E, Marty C, Marie P, Jacquot J. Le Henaff C, et al. Among authors: jacquot j. Am J Pathol. 2012 May;180(5):2068-75. doi: 10.1016/j.ajpath.2012.01.039. Epub 2012 Mar 23. Am J Pathol. 2012. PMID: 22449949

7

Overexpression of RANKL in osteoblasts: a possible mechanism of susceptibility to bone disease in cystic fibrosis.

Delion M, Braux J, Jourdain ML, Guillaume C, Bour C, Gangloff S, Pimpec-Barthes FL, Sermet-Gaudelus I, Jacquot J, Velard F. Delion M, et al. Among authors: jacquot j. J Pathol. 2016 Sep;240(1):50-60. doi: 10.1002/path.4753. J Pathol. 2016. PMID: 27235726

8

Cystic fibrosis bone disease: is the CFTR corrector C18 an option for therapy?

Velard F, Delion M, Lemaire F, Tabary O, Guillaume C, Le Pimpec Barthès F, Touqui L, Gangloff S, Sermet-Gaudelus I, Jacquot J. Velard F, et al. Among authors: jacquot j. Eur Respir J. 2015 Mar;45(3):845-8. doi: 10.1183/09031936.00174014. Epub 2014 Nov 27. Eur Respir J. 2015. PMID: 25431270 Free article. No abstract available.

9

Calcium-dependent regulation of NF-(kappa)B activation in cystic fibrosis airway epithelial cells.

Tabary O, Boncoeur E, de Martin R, Pepperkok R, Clément A, Schultz C, Jacquot J. Tabary O, et al. Among authors: jacquot j. Cell Signal. 2006 May;18(5):652-60. doi: 10.1016/j.cellsig.2005.06.004. Epub 2005 Aug 9. Cell Signal. 2006. PMID: 16084692

10

Airway epithelial cell inflammatory signalling in cystic fibrosis.

Jacquot J, Tabary O, Le Rouzic P, Clement A. Jacquot J, et al. Int J Biochem Cell Biol. 2008;40(9):1703-15. doi: 10.1016/j.biocel.2008.02.002. Epub 2008 Feb 14. Int J Biochem Cell Biol. 2008. PMID: 18434235 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

331 results

Search Page

Filters